CAPN1 and cardiac hypertrophy: The results showed that DAPA could significantly reduce the expression of calpain-1 in myocardial tissue, thereby avoiding the phosphorylation of IκBα to p-IκBα and reducing the transfer of p65 to the nucleus so as to inhibit cardiac hypertrophy.